Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer

Cell Rep. 2023 Dec 26;42(12):113266. doi: 10.1016/j.celrep.2023.113266. Epub 2023 Nov 17.

Abstract

Chromosome instability (CIN) contributes to resistance to therapies and tumor evolution. Although natural killer (NK) cells can eliminate cells with complex karyotypes, high-CIN human tumors have an immunosuppressive phenotype. To understand which CIN-associated molecular features alter immune recognition during tumor evolution, we overexpress Polo-like kinase 1 (Plk1) in a Her2+ breast cancer model. These high-CIN tumors activate a senescence-associated secretory phenotype (SASP), upregulate PD-L1 and CD206, and induce non-cell-autonomous nuclear factor κB (NF-κβ) signaling, facilitating immune evasion. Single-cell RNA sequencing from pre-neoplastic mammary glands unveiled the presence of Arg1+ macrophages, NK cells with reduced effector functions, and increased resting regulatory T cell infiltration. We further show that high PLK1-expressing human breast tumors display gene expression patterns associated with SASP, NF-κβ signaling, and immune suppression. These findings underscore the need to understand the immune landscape in CIN tumors to identify more effective therapies, potentially combining immune checkpoint or NF-κβ inhibitors with current treatments.

Keywords: CP: Cancer; CP: Cell biology; Her2(+) breast cancer; NF-κβ signaling; chromosomal instability; immune evasion; senescence-associated secretory phenotype, SASP; single-cell sequencing.

MeSH terms

  • Animals
  • B7-H1 Antigen / metabolism
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / immunology
  • Cell Line, Tumor
  • Chromosomal Instability*
  • Female
  • Heterografts
  • Humans
  • Immune Tolerance*
  • Killer Cells, Natural / immunology
  • MCF-7 Cells
  • Mannose Receptor / metabolism
  • Mice
  • NF-kappa B / metabolism
  • Polo-Like Kinase 1* / genetics
  • Polo-Like Kinase 1* / metabolism
  • Receptor, ErbB-2 / genetics
  • Tumor Escape*

Substances

  • PLK1 protein, human
  • Polo-Like Kinase 1
  • Receptor, ErbB-2
  • NF-kappa B
  • B7-H1 Antigen
  • Mannose Receptor